GLAUKOS Corp Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
GLAUKOS Corp (GKOS) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value of $30.71 per share for the 3-month period ending 2019-09-30, per its 10-Q filed 2019-11-06.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue · last filed 2019-11-06
- GLAUKOS Corp share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2019-09-30 was $30.71.
- GLAUKOS Corp share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2019-06-30 was $33.02, a 95.27% increase year-over-year.
- GLAUKOS Corp share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2019-03-31 was $33.02, a 6.79% increase year-over-year.
- GLAUKOS Corp share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2018-06-30 was $16.91.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 3 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 9 month |
|---|---|---|---|---|
| 2019-09-30 | $30.71 10-Q · filed 2019-11-06 | $33.02 10-Q · filed 2019-11-06 | ||
| 2019-06-30 | $33.02 10-Q · filed 2019-08-08 | $33.02 10-Q · filed 2019-08-08 | ||
| 2019-03-31 | $33.02 10-Q · filed 2019-05-08 | |||
| 2018-09-30 | $15.19 10-Q · filed 2019-11-06 | |||
| 2018-06-30 | $16.91 10-Q · filed 2019-08-08 | $15.08 10-Q · filed 2019-08-08 | ||
| 2018-03-31 | $30.92 10-Q · filed 2019-05-08 | $14.46 10-Q · filed 2018-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |